Navigation Links
Alzheimer's Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimer's Disease
Date:3/6/2013

NEW YORK, March 6, 2013 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded $205,260 in funding to CohBar Inc. to develop a novel mitochondrial peptide for the treatment of Alzheimer's disease (AD). The peptide has been shown to have neuro-protective effects against a variety of AD-related toxic insults, including amyloid-beta.

Based on a peptide called Humanin, CohBar's peptide acts by preventing neurons from dying, in part by improving mitochondrial function, reducing inflammation, increasing insulin sensitivity and decreasing oxidative stress.

"We are excited to support the development of CohBar's unique peptide, which affects several processes implicated in Alzheimer's disease progression," said Howard Fillit , MD, executive director and chief science officer for the ADDF. "We believe that a compound that targets all of these processes has the potential to be a promising new treatment for patients suffering with this disease."

The ADDF funds will support a year-long research program at CohBar that will include: a) evaluating the ability of the peptides to protect cell lines against a variety of Alzheimer disease related stresses, b) examining evidence that the peptides cross the blood brain barrier and c) an initial evaluation of the efficacy in mice. At the end of the program, researchers at CohBar plan to continue testing in more advanced animal research models of Alzheimer's disease.  

"We are pleased to be selected by the ADDF for this peer-reviewed grant, which recognizes the novelty of our scientific approach and the quality of our research capabilities," said Mark Rampy , PhD, chief executive officer of CohBar. "We look forward to working with the ADDF and advancing our research with novel Humanin analogs in the area of Alzheimer's disease."

John Amatuda
'/>"/>

SOURCE Alzheimer's Drug Discovery Foundation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. TeraDiscoveries to Use its Inverse Design Software Running on Windows Azure to Advance Its Computational Drug Discovery Process
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
4. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
5. Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
6. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
7. Drug Discovery Technologies Market Soars to $79 billion by 2017, Driven by Innovations in Pipeline and Tools Development
8. AMRI Further Expands Discovery Capabilities in India
9. Tetra Discovery Partners Receives Major NIH Award To Develop New Alzheimers Drug
10. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
11. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... TORONTO , May 22, 2013  Medifocus, Inc. (OTCQX: ... Mon , Chief Operating Officer, will present at the ... 2013 in New York City at ... is scheduled to begin at 4:00 p.m. EDT and will ... go to:   http://wsw.com/webcast/marcum/mfs.v/   For more information ...
(Date:5/22/2013)... 22, 2013  BD (Becton, Dickinson and Company) (NYSE: ... company, announced today the publication of its 2012 ... and it continues to focus on the Company,s shared ... the principles of shared value — creating value for ... societies — are fundamental to our strategy," said ...
(Date:5/22/2013)... Cellular Biomedicine Group (OTCQB: CBMG) today announced that ... projected enrollment required for its Phase I trial to evaluate ... Specific Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most ... had no Severe Adverse Effect (SAE) reported. The ... with NIH under number NCT01828762 (click here to view) ...
Breaking Medicine Technology:Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 2Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer 3
... 7, 2011 Stereotaxis, Inc. (NASDAQ: STXS ) ... 30, 2011.   Third Quarter 2011 ... down 38% from the year ago period.  The decrease was ... from market demand for a more efficient solution for complex ...
... CARLSBAD, Calif., Nov. 7, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... the quarter ended September 30, 2011.  The Company finished the ... loss (NOL) of $20.0 million and $44.9 million for the ... to a pro forma NOL of $6.0 million and $23.1 ...
Cached Medicine Technology:Stereotaxis Reports Third Quarter Financial Results 2Stereotaxis Reports Third Quarter Financial Results 3Stereotaxis Reports Third Quarter Financial Results 4Stereotaxis Reports Third Quarter Financial Results 5Stereotaxis Reports Third Quarter Financial Results 6Stereotaxis Reports Third Quarter Financial Results 7Stereotaxis Reports Third Quarter Financial Results 8Isis Reports Financial Results and Highlights for Third Quarter 2011 2Isis Reports Financial Results and Highlights for Third Quarter 2011 3Isis Reports Financial Results and Highlights for Third Quarter 2011 4Isis Reports Financial Results and Highlights for Third Quarter 2011 5Isis Reports Financial Results and Highlights for Third Quarter 2011 6Isis Reports Financial Results and Highlights for Third Quarter 2011 7Isis Reports Financial Results and Highlights for Third Quarter 2011 8Isis Reports Financial Results and Highlights for Third Quarter 2011 9
(Date:5/22/2013)... Seva Call (Save-A-Call) has launched in ... and connects consumers to the right available professional by ... to handle personal matters than the national and state ... work. So, they really can’t afford the 30 minutes ... professional. , Now, Detroit residents will be able to ...
(Date:5/22/2013)... 22, 2013 LDM Global ( http://www.ldmglobal.com ... services for law firms, corporations and government agencies announces ... cloud-based e-discovery software company, to deliver defensible ESI collections ... partnership, Cumulus Data and LDM Global hosted a VIP ... Tuesday, May 21st. This event was in conjunction ...
(Date:5/22/2013)... Many people across the United States ... how to lose weight safely and rapidly. Unfortunately, crossing ... demotivate people to continue their journey toward healthy eating ... on Medical News Today offers credence to ... and actually losing those initial pounds can prove extremely ...
(Date:5/22/2013)... 22, 2013 Athletic-Minded Traveler LLC, ... company released today its 2013 U.S. Business Hotel ... received the company’s recommendation after ongoing research of ... tours by the editorial staff. Selection criteria ... sport court, etc.), in-room workout choices, healthy food ...
(Date:5/21/2013)... Heritage Woods of Dwight , a ... living community, is hosting a Quality Home Health informational program ... on Tuesday, May 28. , The community, which is located ... of all incomes, including those on Medicaid, who need some ... open to the public. There is no cost to ...
Breaking Medicine News(10 mins):Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2
... HealthDay Reporter , WEDNESDAY, Dec. 21 (HealthDay News) ... people are suffering from acid reflux, likely increasing the number ... suggests. In Norway, the prevalence of acid reflux, also ... in the past 10 years, say researchers led by ...
... -- Hepatitis B vaccination is recommended for all unvaccinated adults ... 59, say new guidelines from the U.S. Advisory Committee on ... soon as possible after adults in this age group are ... older than 59 can receive hepatitis B vaccination at the ...
... 2011 Elsevier,s Journal of Clinical Virology ... and Prevention (CDC) today announced the publication of a ... This timely supplement contains articles which summarize studies since ... new US HIV diagnostic testing algorithm. In addition, review ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... was wrong when it got harder and harder to walk ... where he worked. He knew something was terribly ... consultation with an oncologist confirmed Whelan,s fears: He had advanced ...
... Dec. 22 (HealthDay News) -- Use of gastric bands as ... alert for potential complications years later, say the authors of ... developed two years after a 49-year-old British woman underwent the ... night sweats and a persistent cough that produced green and ...
... HealthDay Reporter , WEDNESDAY, Dec. 21 (HealthDay News) -- ... are thinner in older people who may be destined to ... the information to help people fend off dementia. Still, ... them to track the progression of the disease, said study ...
Cached Medicine News:Health News:As Obesity Rises, More Suffer From Acid Reflux 2Health News:Hepatitis B Vaccine Recommended for Adults With Diabetes 2Health News:40 Years On, the Triumphs and Challenges of America's 'War on Cancer' 2Health News:40 Years On, the Triumphs and Challenges of America's 'War on Cancer' 3Health News:40 Years On, the Triumphs and Challenges of America's 'War on Cancer' 4Health News:40 Years On, the Triumphs and Challenges of America's 'War on Cancer' 5Health News:As Gastric Banding Increases, So May Complications 2Health News:Thinner Brains Could Signal Alzheimer's, Study Suggests 2
... The K-ASSAY Liquid Lipid Control is intended ... a consistent test sample of known concentration ... determinations. Include K-ASSAY Liquid Lipid Control with ... of the listed constituents. The user can ...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...
... The Directigen EZ Flu A+B test is ... and qualitative detection of influenza A and ... throat swabs of symptomatic patients. The Directigen ... test, such that influenza A viral antigens ...
Medicine Products: